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Abstract
The Glucocorticoid Receptor (GR) is a transcription factor ubiquitously expressed in the brain. Activation of brain GRs by
high levels of glucocorticoid (GC) hormones modifies a large variety of physiological and pathological-related behaviors.
Unfortunately the specific cellular targets of GR-mediated behavioral effects of GC are still largely unknown. To address this
issue, we generated a mutated form of the GR called DGR. DGR is a constitutively transcriptionally active form of the GR that
is localized in the nuclei and activates transcription without binding to glucocorticoids. Using the tetracycline-regulated
system (Tet-OFF), we developed an inducible transgenic approach that allows the expression of the DGR in specific brain
areas. We focused our study on a mouse line that expressed DGR almost selectively in the glutamatergic neurons of the
dentate gyrus (DG) of the hippocampus. This restricted expression of the DGR increased anxiety-related behaviors without
affecting other behaviors that could indirectly influence performance in anxiety-related tests. This behavioral phenotype
was also associated with an up-regulation of the MAPK signaling pathway and Egr-1 protein in the DG. These findings
identify glutamatergic neurons in the DG as one of the cellular substrate of stress-related pathologies.
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Introduction
Glucocorticoid hormones (GC) are the end product of the
activation of the hypothalamus-pituitary-adrenal (HPA) axis. The
secretion of these hormones increases during the active phase of the
circadian cycle and in response to stress [1,2]. Glucocorticoids through
their action on the brain have large effects on adaptive behaviors and
are involved in the pathophysiology of several stress-related disorders
such as drug abuse, depression and anxiety [2–5,5–9].
Most of the behavioral and stress-related effects of glucocorti-
coids depend on the activation of Glucocorticoid Receptors (GR).
GRs are hormone-activated transcription factors [10] that upon
binding to glucocorticoids, translocate to the nucleus where they
modify the expression of target genes through many different
molecular mechanisms [11].
GRs are expressed in most brain cells and the glucocorticoids
access different brain areas equipotently. As a consequence the
specific cellular targets of the effects of GR activation on normal
and pathological behaviors remain largely unknown. Identifying
the specific cellular targets of GR effects on behavior is of the
utmost importance. Thus, the molecular effects of GR largely vary
as a function of the cellular type. Consequently, molecular
mechanisms of glucocorticoid-mediated pathologies can only be
understood once the specific cellular targets of these hormones
have been identified.
In order to address this issue, using the tetracycline-regulated
system (Tet-OFF system) [12–15], we developed an inducible
transgenic approach with which a mutated form of the GR, called
DGR can be expressed in specific brain areas. Compared to the
wild-type GR, DGR lacks the Hormone Binding Domain (HBD)
and the AF2 transcriptional activation domain [16,17] and has a
nuclear localization sequence (nls) instead that confers two
essential properties: (i) DGR is mainly expressed in the nucleus
and (ii) it is constitutively active and highly specific for the
Glucocorticoid Responses Elements (GRE) [8]. As a consequence
DGR overexpression reproduces the transcriptional effects of GR
activation independently of glucocorticoid presence. Therefore
DGR can be seen as a GR-molecular agonist with which GR-
mediated transcriptional effects of stress in a specific cellular target
can be reproduced in vivo. This approach bypasses several biases
introduced by overexpressing the wild-type GR and submitting the
animals to an actual stress. Thus in the latter case glucocorticoids
levels need to be increased to activate the overexpressed wild-type
GR. It will then be impossible to eliminate the influence of: 1. GR-
independent effects of glucocorticoids; 2. Transcription-indepen-
dent effects of GC-activated GR; 3 The effects mediated by the
activation of the endogenous GR in other cellular types [18,19].
In this report we used a transgenic approach that allows
expression of the DGR prevalently in glutamatergic neurons of the
dentate gyrus (DG) of the hippocampus. In these mutant animals
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7704DGR overexpression was stably induced at five months of age.
These animal models then mimic the effects of certain forms of
chronic stress specifically in this neuronal population in which the
circadian secretion of glucocorticoids is lost and glucocorticoid
levels are permanently high [20,21].
In these animals we investigated anxiety-related behaviors,
using the elevated plus maze and the emergence test. We also
analyzed other GR-mediated behaviors that might indirectly
modify performances in anxiety tests. We also studied the MAPK
signaling pathway and the downstream MAPK-regulated protein
Egr-1 since in the hippocampus they are regulated by the GR.
Results
Transgenic model for selective inducible overexpression
of DGR in vivo
The selective inducible overexpression of DGR (Figure 1A, [8])
was obtained using the tetracycline-controlled transactivator
(tTA)-regulated system (Tet-OFF system). We used a bidirectional
construct allowing the co-expression of the Enhanced Green
Fluorescent Protein (EGFP) and DGR under the control of
Tetracycline Response Elements (TRE), which can be activated by
the tTA protein in the absence of tetracycline’s analogue
doxycycline (Dox) [8,12] (Figure 1B). The transgenic mice
integrating this bidirectional construct (Tet-DGR/EGFP) were
then crossed with regulatory mice in which the tTA transgene was
controlled by the Eno2 (Neuron Specific Enolase: NSE) promoter
[12,13] (Figure 1C).
Anatomical and cellular localization of EGFP and DGR
transgene expression in vivo
We first studied transgene expression by analyzing the pattern
of EGFP expression in Eno2-DGR/EGFP mice maintained in
doxycyline-free condition from birth to adulthood. We found only
a few scattered EGFP positive cells in layer 5/6 in the cortex
(Figure 1D, E) and a strong expression in the dentate gyrus of the
hippocampal formation (Figure 1D, F).
A time course of the expression of the transgenes in Eno2-DGR/
EGFP mice raised in doxycycline-free conditions revealed that the
transgenes were only expressed in adulthood, starting at four
months of age with maximum expression at around five months of
age (Figure 2). Thus, for the following sets of experiments, Eno2-
DGR/EGFP mice were maintained in doxycycline-free conditions
and studied between five and six months of age, which corresponds
to the optimal period of transgene activation. For each experiment
transgene activation was verified before the start of the experiments
and after the end of the experiments in all animals.
The phenotype of cells co-expressing EGFP and DGR proteins
was analyzed using immunocytochemistry (Figure 3). In the DG,
Figure 1. Expression pattern of EGFP and DGR proteins using the Tet-OFF system in genetically-modified mice. (A) DGR differs from
the endogenous GR by an absence of the hormone binding and AF2 transcription domains which have been replaced by a C-terminal nuclear
localization sequence to direct nuclear expression. (B) Schematic representation of the inducible Tet-OFF system. tTA expression is driven in vivo by
the Enolase (Eno2) promoter. In absence of doxycycline (Dox), tTA protein binds to seven TetO sequences (TRE) to drive the co-transcription of EGFP
and DGR transgenes. (C) Strategy to obtain Dox-dependent co-expression of EGFP and DGR proteins in vivo in double transgenic Eno2-DGR/EGFP
mice. (D) EGFP expression was observed in coronal brain sections from Eno2-DGR/EGFP mice maintained in doxycycline-free conditions. (E) Few cells
with weak EGFP expression were observed in the cortex. (F) Strong EGFP expression in the dentate gyrus of the hippocampal formation.
doi:10.1371/journal.pone.0007704.g001
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and in cells expressing the Neuron-Specific Enolase (NSE). This
result indicated that the tTA protein under the control of the Eno2
promoter used to induce EGFP and DGR transgenes is highly
specific to this neuronal subtype. The transgene seemed to be
selectively expressed by glutamatergic neurons since the EGFP
protein was also coexpressed with Glutamate (Figure 3). Similar
results were obtained for the few neurons that expressed EGFP in
the cortex (Supplementary Figure S1).
DGR expression was studied using western blotting since this
protein cannot be distinguished from the wild-type GR using
immunohistochemistry. Thus, the DGR has the same structure as
the wild-type GR except for the lack of hormone binding and the
AF2 transcriptional activation domains. In contrast, the smaller
DGR is easily detectable by western blotting. We found an
expression of EGFP and DGR proteins in the hippocampus of
bigenic mice (Figure 4A) with no modification in the quantity and
the distribution of the endogenous GR (Figure 4B, t16=0.139
p.0.889). These findings are consistent with the immunohisto-
chemistry results. EGFP and DGR were not detectable by western
blotting in the cortex of bigenic mice. This is not surprising given
the low number of positive cells and the low level of expression in
this structure found using immunohistochemistry.
This very restricted spatial and temporal pattern of expression
of this line of Tet-DGR/EGFP transgenic mice is probably due to
the site of integration of the transgene within the genome. In
addition it could also be due to the insertion of a low number of
copies of the bidirectional construct into the genome [22,23]. In
order to explore the latter possibility, we determined the number
of copies using real time quantitative PCR (qPCR) [24,25] and
found that these transgenic mice inserted only 2 copies of
the bidirectional Tet-DGR/EGFP construct (Supplementary
Figure S2).
Glucocorticoid secretion in Eno2-DGR/EGFP bigenic mice
We then analysed the potential modification of the HPA axis in
Eno2-DGR/EGFP mutant mice. In order to analyze corticoste-
rone secretion during the circadian cycle, plasma samples were
collected 1 hour after lights on and 1 hour after lights off. These
two time points correspond to the lowest and highest levels of
corticosterone circadian secretion respectively [26]. Bigenic mice
overexpressing DGR and their control littermates did not differ in
terms of corticosterone secretion during the circadian cycle
(Figure 5A, AM: t23=1.729 p.0.097; PM: t23=0.543 p.0.59)
or the weight of the adrenal gland (data not shown). We also
analyzed corticosterone secretion following acute stress (Figure 5B).
In both control and mutant animals, 30 minutes of stress increased
corticosterone levels. Over the following two hours, corticosterone
secretion progressively returned to basal levels. Stress-induced
corticosterone secretion was significantly lower in bigenic animals
(Group effect: F1,20=5,00 p,0.037) as also shown by the analysis
of the area under the curve (Figure 5B, inset: t21=3.068 p,0.006).
Behavioral phenotypes of Eno2-DGR/EGFP bigenic mice
Anxiety-related behaviors. The Elevated Plus Maze (EPM)
is one of the most widely used tests for evaluating anxiety-related
behavior. In this test, the animal is placed in the center of an
elevated cross and can choose to walk in any of the four arms of
the maze. Two of the opposite arms do not have walls (open arms)
and are considered by mice as a threatening area. We used the
time spent and number of entries into the open arms as a measure
of anxiety [27] and into closed arms as a measure of locomotor
activity [28]. Eno2-DGR/EGFP bigenic mice spent less time and
visited the open arms and their extremities less often than control
littermates (Figure 6A–C, A: t17=2.993 p,0.0087; B: t17=2.128
p,0.049; C: t17=2.273 p,0.037) suggesting an increase in
anxiety-related behaviors. Changes in open arm exploration were
not secondary to non-specific modifications of locomotor activity
since closed arm entries were not modified between the mutant
and control mice (Figure 6D, t17=0.784 p.0.444).
In order to further verify these findings we studied the effects of
the reference anxiolytic, benzodiazepine chlordiazepoxide (CDZ)
on Eno2-DGR/EGFP bigenic mice. The administration of chlor-
diazepoxide (CDZ, 7.5 mg/kg/ip) to Eno2-DGR/EGFP bigenic
mice largely reversed the anxiety-related phenotype observed in
Eno2-DGR/EGFP bigenic mice treated with vehicle (Figure 6E–G,
Figure 2. Spatial and temporal pattern of expression of EGFP
transgene from 1 week to 24 week-old bigenic Eno2-DGR/EGFP
mice. Schematic diagrams taken from the Paxinos and Watson atlas
(1986), show the representative pictures for the cortical and dentate
gyrus regions (red frame). 20 week-old control littermates were used as
an immunohistochemical negative control.
doi:10.1371/journal.pone.0007704.g002
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PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e7704Figure 3. Cellular characterization of cells expressing EGFP and DGR proteins in the dentate gyrus of Eno2-DGR/EGFP bigenic mice.
Confocal illustrations of neurons from the dentate gyrus co-expressing EGFP protein and specific neuronal markers visualized with Cy
3-conjugated
antibodies. Distribution of EGFP and endogenous neuronal markers (NeuN, NSE, Glutamate) and merges of the two signals are shown.
doi:10.1371/journal.pone.0007704.g003
Figure 4. Expression of EGFP and DGR and GR proteins in the hippocampus. (A) Western blotting showing EGFP and DGR proteins in
extracts from hippocampi dissected from control littermates (2) and Eno2-DGR/EGFP mice (+). Positive controls (ctrl) were obtained from protein cell
extracts from CHO-K1 Tet-ON cells transfected with EGFP-TetO-DGR expression vector [8]. (B) Nuclear wild-type GR protein from hippocampi of Eno2-
DGR/EGFP bigenic mice (n=11) and control littermates (n=7) were analyzed by western blot and quantified by densitometry (optical density, OD,
means +/2 sem).
doi:10.1371/journal.pone.0007704.g004
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p.0.127). These results were not due to the non-specific effects of
the mutation or of the pharmacological treatments since the
number of entries in the closed arms did not differ between groups
(Figure 6H, t7=1.055 p.0.325).
In order to analyze whether the observed phenotype was due to
the expression of the DGR we studied anxiety-related behavior in
the EPM in three month-old Eno2-DGR/EGFP bigenic mice, i.e.
before these mice expressed the DGR transgene (Figure 7A–B). No
behavioral differences in the EPM were found between Eno2-
DGR/EGFP bigenic mice and control littermates (Figure 7C–F,
C: t18=20.983 p.0.337, D: t18=21.288 p.0.212, E:
t18=1.010 p.0.324, F: t18=1.606 p.0.124). These results
suggest that the increase in anxiety-related behaviors observed in
Eno2-DGR/EGFP bigenic mice at five months of age (Figure 6) is
due to the expression of the DGR.
Figure 5. Basal and stress-induced corticosterone secretion in Eno2-DGR/EGFP bigenic mice. (A) Plasma corticosterone concentrations
were determined in basal conditions from blood collected either one hour after light on (AM=8 am) or one hour after light off (PM=8 pm), these two
time points correspond respectively to the lowest and highest levels of corticosterone during circadian secretion. Control (n=15) and Eno2-DGR/
EGFP bigenic mice (n=10). (B) Kinetics of glucocorticoid secretion in response to stress (30 minutes of forced exposure to an open field). Mice were
bled several times related to each time point and blood samples were collected from control (n=13) and Eno2-DGR/EGFP bigenic mice (n=10) 60
minutes before the beginning of the stress (t-60), at the end of the stress (t30), then 75, 120 and 180 minutes after the beginning of the stress. Insert
represents the area under the curve; **=P,0.01. Plotted values are means +/2 sem.
doi:10.1371/journal.pone.0007704.g005
Figure 6. Anxiety-related behaviors in Eno2-DGR/EGFP bigenic mice. (A–D) Anxiety-related behavior was assessed with the elevated plus
maze (EPM) test. Compared to control littermates (n=11), Eno2-DGR/EGFP bigenic mice (n=8) spent less time in the open arms section (A, B) and
made fewer entries into the open-arm extremities (C) than into the closed arms (D). (E–H) In comparison to Eno2-DGR/EGFP bigenic mice treated
with vehicle (Black bars, n=4), intraperitoneal injection of chlordiazepoxide (CDZ; 7.5 mg/kg/ip) to Eno2-DGR/EGFP bigenic mice (Gray bars, n=5) 15
minutes before the EPM test completely reversed this phenotype increasing the time spent in the open arms (E, F) and the entries in the arms
extremities (G). Motor activity measured by entries into the closed arms did not differ between the two groups (H). Values shown are means +/2
sem. *=P,0.05; **=P,0.01.
doi:10.1371/journal.pone.0007704.g006
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DGR/EGFP bigenic mice in the emergence test (Figure 8A, B)
which is also widely used to analyze anxiety-related behavior. In
this test, the animal is placed in an opaque plastic cylinder located
in a brightly lit open field. The cylinder and the open field are
respectively a protective and a threatening environment for the
mice. Eno2-DGR/EGFP bigenic mice had significantly longer
latencies before emerging from the protective cylinder, indicating
higher anxiety when faced with the threatening open field
(Figure 8A, t21=23.706 p,0.0014). These results were not due
to a non specific impairment of motor behavior since once out of
the cylinder there was no difference in total motor activity between
the two strains (Figure 8B, t21=1.497 p.0.148).
We then analyzed the behavior of Eno2-DGR/EGFP mice in the
forced swim test (Figure 8C, D) which is the most widely used
behavioral measure to screen for antidepressant drugs [29].
However, in animal models anxiety and depression are not two
dimensions that can be easily separated and most tests actually
screen different forms of behavioral responses to unavoidable
aversive situations. In the forced swim test, mice are forced to swim
in a small transparent cylinder. After unsuccessful attempts to
escape, mice stop swimming and float. We measured both the
latency and the duration of immobility as a measure of despair
(learned helplessness) [29–31]. Eno2-DGR/EGFP bigenic mice
showed a lower latency to the first immobilization (Figure 8C,
t14=2.650 p,0.021) and increased duration of immobility
compared to controllittermates (Figure 8D,t14=22.797 p,0.015).
The time spent in novel open areas, usually used to measure
anxiety, results from the computation of two opposite motivational
forces. The fear of potential threats driving avoidance, and
novelty-seeking driving exploration. Consequently, a decrease in
the time spent in the open arms of the EPM or an increase in the
latency in exiting the protective cylinder in the emergence test
could result from either an increase in the fear of potential threats
or a decrease in novelty exploration. In order to address this issue,
we evaluated Eno2-DGR/EGFP bigenic mice for the exploration
of a novel object in a non-threatening environment [32]. For this
test animals are first habituated to the test apparatus in the absence
of the object in order to diminish the fear component of exposure
to an unknown environment (session 1: S1). Then, in a subsequent
session a novel object is added (session 2: S2). Exploration of the
novel object is measured by comparing the distance (Figure 9A)
and the time spent (Figure 9B) into a zone of the open field in the
presence or in the absence of the novel object. In these conditions,
it was found that exploration of a novel object (Figure 9, A:
t18=20.835 p.0.413; B, t18=20.324 p.0.748) did not differ
between bigenic and control littermates.
Taken together these results indicate that Eno2-DGR/EGFP
bigenic mice have an increase in stress-related behavior and in
particular in behaviors suggesting higher anxiety and despair
induced by aversive situations.
Circadian and novelty-induced locomotor activation.
Glucocorticoid hormones have been involved in the regulation of
locomotor activation. In order to further verify that DGR
overexpression in the DG did not modify locomotor activity in
Figure 7. Anxiety-related behavior assessed in the EPM test on
three month-old Eno2-DGR/EGFP bigenic mice. Three month-old
Eno2-DGR/EGFP bigenic mice did not express EGFP and DGR transgenes
in the cortex (A) and in the DG (B) and did not display anxiety-related
behavior (C–F). Compared tocontrol littermates(n=10), Eno2-DGR/EGFP
bigenic mice (n=10) spent the same amount of time in the open arms
section (C–D) and made equal entries into the open arms extremities (E)
than into the closed arms (F). Values shown are means +/2 sem.
doi:10.1371/journal.pone.0007704.g007
Figure 8. Anxiety- and depression-related behaviors in Eno2-
DGR/EGFP bigenic mice. Anxiety-related behavior was measured in
the emergence test. The latency to emerge from the dark cylinder was
significantly longer in Eno2-DGR/EGFP (n=10) than in control littermate
(n=13) (A). However, motor activity was comparable once outside the
cylinder (B). In the forced swim test, which is commonly used to screen
for antidepressant, the latency to the first immobilization was
significantly lower (C) and the duration of immobility was increased
(D)i nEno2-DGR/EGFP mice (n=9) than in control littermates (n=7).
Values shown are means +/2 sem. *=P,0.05; **=P,0.01.
doi:10.1371/journal.pone.0007704.g008
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during the active phase of the circadian cycle and induced by a mild
stress, such as the forced exposure to a novel environment. Both these
behaviors are believed to involve the activation of the GR by
glucocorticoids [6]. We found that DGR overexpression did not
modify locomotor activity during the circadian cycle (Figure 10A,
Group x Time interaction: F41,902=0.916 p.0.621) and had no effect
on the Night/Day ratio, an index of the rhythmic activity (Figure 10B,
t17=20.078 p.0.937). In addition, there was no difference in
novelty-induced locomotion between bigenic and control mice
(Figure 10C, Group x Time interaction: F11,209=1.073 p.0.383;
inset: t20=0.085p.0.931).
Spatial memory. Activation of the GR by glucocorticoid
hormones has also been been implicated in the regulation of
learning and memory and in particular spatial memory [33] a
cognitive function that strongly involves hippocampal formation
[34]. Hippocampus-dependent spatial navigation was studied here
using the water maze task. In this behavioral procedure the animal
has to learn the location of a hidden platform using distal cues
while the starting position is changed at each trial. This procedure
requires the hippocampus since the animal has to learn the
positional relations among multiple independent environmental
cues (‘‘spatial relational memory’’) in order to find the hidden
platform. Eno2-DGR/EGFP bigenic mice and their control
littermates showed similar learning of the location of the
platform during training (Figure 10D, Group x Time
interaction: F9,198=0.523 p.0.855). These results were
confirmed by a probe test, in which the hidden platform is
removed. This procedure measures over 60 seconds the time spent
by the animal in the quadrant where the platform was located
during training (target quadrant). Both strains showed a similar
memory of the platform location during a probe test, spending
more than 40% of their time in the target quadrant (Figure 10E,
t22=1.077 p.0.292). Altogether, these results indicate that the
overexpression of the DGR did not modify spatial memory.
MAPK signaling and Egr-1 up-regulations in Eno2-DGR/
EGFP bigenic mice
We finally investigated whether DGR overexpression in the
hippocampus leads to alteration in expression and activity of target
Figure 10. Circadian and novelty-induced locomotion and
spatial memory in Eno2-DGR/EGFP bigenic mice. (A) Recording of
locomotor activity, measured by photocell beam breaks over two days
did not reveal any differences between mutants (n=8) and control mice
(n=11). White and dashed boxes represent the light and dark cycle
respectively. (B) The amplitude of the circadian rhythm measured by
the ratio between locomotor activity during the light and dark periods
was not different between Eno2-DGR/EGFP bigenic mice and control
littermates. (C) Novelty-induced locomotor activity was measured by
photocell beam breaks during two hours of forced exposure to a novel
activity box. Inset: total activity during the two hour period. No
differences in locomotor activity were observed between control
littermates (n=13) and Eno2-DGR/EGFP bigenic mice (n=9). (D) Spatial
learning in Eno2-DGR/EGFP bigenic mice was tested in the Morris water
maze test. Mice have to find a hidden platform using extra maze cues.
Latency to reach the platform from variable start positions decreased
over time similarly in mutants (n=10) and control mice (n=14). (E)
During the probe test, the platform is removed from the pool and the
time spent in the target quadrant, the one previously containing the
platform, is measured. No differences were observed between Eno2-
DGR/EGFP bigenic mice (n=10) and control littermates (n=14). Values
shown are means +/2 sem.
doi:10.1371/journal.pone.0007704.g010
Figure 9. Novelty-induced explorations in Eno2-DGR/EGFP
bigenic mice. Exploration of a novel stimulus was performed in a
familiar environment using the novel object test. The S2/S1 ratio is
respectively a measure of (A) the distance covered or (B) the time spent
in the centre of the apparatus in presence of the object in session 2 (S2)
over the distance or the time spent in the centre of the apparatus
without the novel object during session 1 (S1). These ratios indicate that
the novel object increased exploration similarly in both genotypes.
Control littermates mice (n=9), Eno2-DGR/EGFP bigenic mice (n=11).
Values shown are means +/2 sem.
doi:10.1371/journal.pone.0007704.g009
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structure. For this purpose we studied a key member (Erk1/2) of
the MAPK signaling pathway and the downstream-regulated
Egr-1 protein. Both Erk1/2 phosphorylation and Egr-1 transcrip-
tion are activated by the GR and involved in the behavioral
response to threatening stimuli [8]. Both nuclear phosphorylated
and unphosphorylated Erk1/2 as well as Egr-1 proteins were
up-regulated in the hippocampus of Eno2-DGR/EGFP bigenic
mice (Figure 11A, B, MAPK: t16=22.747 p,0.0144; P-MAPK:
t16=22.194 p,0.0434; Egr-1: t16=22.882 p,0.02; betaIII
tubulin: t16=0.714 p.0.485). Further immunohistochemical
analysis showed that Egr-1 expression was increased in the DG
Figure 11. Stimulation of the MAPK pathway and Egr-1 by DGR in Eno2-DGR/EGFP bigenic mice. (A) Nuclear non-phosphorylated,
phosphorylated Erk1/2 and Egr-1 proteins from hippocampi of Eno2-DGR/EGFP bigenic mice (+) (n=9) and control littermates (2) (n=9) were
analyzed by western blot. BetaIII-tubulin was used as a loading control. (B) The corresponding X-Ray films were quantified by densitometry (optical
density, OD, means +/2 sem) and showed a higher expression of the proteins studied in Eno2-DGR/EGFP bigenic mice. (C) Confocal illustration of
neurons expressing Egr-1 within the dentate gyrus of Eno2-DGR/EGFP bigenic mice and control littermates. (D) Number of Egr-1 expressing neurons
in the dentate gyrus of Eno2-DGR/EGFP bigenic mice (black, n=4) and control littermates (white, n=4). (E) Confocal illustration of neurons co-
expressing EGFP (green) and Egr-1 (red) in the dentate gyrus of Eno2-DGR/EGFP bigenic mice; the cells were counterstained with DAPI (blue). (F)
Percentage of Egr-1 expressing neurons within the different subpopulation of cells in the dentate gyrus of Eno2-DGR/EGFP bigenic mice and control
littermates. Values shown are means +/2 sem. *=P,0.05, **=P,0.01, ***=P,0.001.
doi:10.1371/journal.pone.0007704.g011
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p,0.0008) and prevalently within the neuronal subpopulation
expressing the DGR (Figure 11E, F; Eno2-DGR/EGFP mice
versus control for Egr-1 in EGFP negative cells: t6=26.697
p,0.00054; Egr-1 in EGFP positive versus EGFP negative cells in
Eno2-DGR/EGFP mice: t6=24.672 p,0.00343).
Discussion
In this report, using the tetracycline-regulated system (Tet-
OFF), we created a conditional transgenic mouse line that
expresses a nuclear constitutively active form of the GR (DGR)
prevalently in glutamatergic neurons of the dentate gyrus (DG) of
the hippocampus. DGR lacks the hormone-binding and AF2
transcriptional activation domains and is able to activate GR-
mediated transcription in the absence of glucocorticoids. Thus, the
transcriptional effects of selectively activated GR in the target
population of neurons can be mimicked with this protein. DG-
Eno2-DGR/EGFP bigenic mice displayed enhanced stress-related
behaviors and in particular higher anxiety- and depression-related
behaviors in response to unavoidable aversive situations. Con-
versely, other behaviors, such as novelty exploration, locomotor
activity and spatial learning, which could influence the perfor-
mance in anxiety tests, were not modified. The behavioral
phenotype in DG-Eno2-DGR/EGFP was associated with an up-
regulation of the MAPK cascade and the downstream-regulated
Egr-1 protein.
A novel inducible transgenic strategy to study the role of
the GR in a specific brain region
We generated several lines of DGR/EGFP mice. We observed
that depending on the line, the expression pattern of EGFP in
doxycycline-free conditions could vary and be different from the
one described by Chen and coworkers [13] for the Enolase
transgene. For example the line used in this paper (Line 27; L27)
exhibited strong expression only at the adult stage within the
dentate gyrus of the hippocampal formation, and very weak
expression in a few cells in the cortex. On the other hand, a second
mouse line we generated (Line 23; L23) did not express the DGR
in the DG, whilst it showed strong expression in the cortex, the
dorsal and ventral striatum, and the CA1 of the hippocampus
(Supplementary Figure S3).
This variability in transgene expression is caused mainly by the
stochastic event of transgene integration within the host genome
and the nature of the transgenic constructs (i.e. minimal
promoter). It is well accepted that host sequences surrounding
the site of transgene integration but also transgene copy numbers,
methylation at the transgene locus and heterochromatin-induced
position effect variegation (PEV) can modify the expected
expression pattern, potentially causing it to be ectopic, weak,
delayed or even undetectable. This is currently interpreted as the
result of chromosomal position effects [22,23,35–37]. These
caveats however also provide the possibility of generating mice
strains with partially overlapping and distinct patterns which can
be used to study the role of a target protein, in our case the GR, in
selective brain structures.
Behavioral effects of the transcriptional activation of the
GR in the Dentate Gyrus
The hippocampal formation is known to be involved in most of the
glucocorticoid-mediated behaviors studied in this report. Our results
indicate that the selective activation of GR in glutamatergic neurons of
the DG is a sufficient condition to modify anxiety-related behaviors, as
measured by EPM,emergence and forcedswimtests.The relationship
of the phenotypes observed in animals overexpressing the DGR in the
DG with anxiety is strengthened by the observation that treatment
with the prototypical anxiolytic CDZ completely abolished the
enhanced response of these animals in the EPM.
It is noteworthy that the forced swim test has also been linked to
depression and is largely used to screen for antidepressants.
Several data indicate that anxiety disorders share common
symptoms with depression and anxiety and depression frequently
coexist [38]. Furthermore, most antidepressants also have
anxiolytic effects [39]. This is probably why overexpression of
the DGR in a specific cellular target modified both prototypical
anxiety-related behaviors and the forced swim test.
The very restricted expression of DGR in the mouse line used in
these experiments suggests that the phenotype observed is likely
due to the over-activation of the DGR in the DG. This idea is also
supported by behavioral results we obtained in another mouse line
(Line 23) which expressed the DGR in several brain structures but
not in the DG (Supplementary Figure S3). Thus, in Line 23 the
elevated plus maze, the emergence test and the forced swim test
were not modified (Supplementary Figure S4).
A prominent role of the DG in some of the hippocampus-
mediated behaviors is consistent with the anatomical position of
this structure in the hippocampal circuitry since the DG is the
entry point for afferences to the hippocampus which receives its
major inputs from the cortex [40].
The finding of increased anxiety and despair in DGR mice is
also consistent with previous publications. It has been shown that
mice in which the gr gene has been knocked out in the whole brain
demonstrate a decrease in anxiety-related behaviors as measured
by the zero maze, a variant of the EPM [41,42]. Conversely, an
overexpression of wild-type GR in the entire forebrain (GRov) has
been observed to induce an increase in anxiety-related behaviors
in the EPM and a shorter latency to immobilization in the forced
swim test [43].
Our findings extend these previous observations by showing
that the selective activation of GRs selectively in the glutamatergic
neurons in the DG is a sufficient condition to induce these
behavioral phenotypes. They also indicate that the hormone
binding and the AF2 transcriptional activation domains of the GR
molecule, lacking in the DGR are not the structural domains
involved in the establishment of these stress-related behaviors in
the DG.
It has previously been suggested, using hippocampal lesions,
that the hippocampus is also involved in anxiety-related behavior
[44,45]. Our data highlight an important role for the DG in
anxiety-related processes. Our findings are in line with three
recent reports. First, it has been shown that the suppression of
neural activity in the DG reverses the anxiety-related phenotype of
Htr1aKO mice [46]. Secondly, selective inhibition of neurogenesis
in the dentate gyrus of the hippocampus has been found to induce
a strong increase in anxiety-like behaviors [47]. Thirdly, mice in
which the GR has been disrupted using a lentivirus-based strategy
in the central nucleus of the amygdala (CeA), did not display a
decrease in innate fear but showed deficits in fear conditioning
[48–50]. The latter observation suggests that GR in the CeA, a
structure strongly implicated in anxiety-related process [48–50],
may be implicated in learned fear, whilst GR in the DG could
mediate innate fear responses like those measured in the EPM and
emergence tests [51,52].
Specificity of the behavioral effects of the GR in the
Dentate Gyrus
Overexpression of DGR in the DG seems to modify anxiety-
related behavior in a specific way. Thus other behaviors such as
GR in the DG Increase Anxiety
PLoS ONE | www.plosone.org 9 November 2009 | Volume 4 | Issue 11 | e7704novelty seeking, motor activity and spatial memory that could
indirectly modify performances in anxiety-related tests were
unchanged in our experimental conditions.
The lack of these effects is not all that surprising. Although the
hippocampus seems to play a role in modulating novelty seeking,
this behavior is thought to be controlled mainly by the dopamine
circuit in the basal ganglia, a brain region that did not express
DGR in our mouse line. In parallel, the regulation of circadian
activities by the GR involves several brain regions at the same time
[53] and consequently could be unaffected by the selective
modification of GR activity in the DG. The results concerning
spatial memory might seem more surprising since both the GR
and the hippocampus have been implicated in the regulation of
this behavior [33,34,54,55]. One explanation for these discrepan-
cies is that a larger impact on the hippocampus is probably
necessary to modify spatial memory and that restricted modifica-
tion of the GR in DG glutamatergic neurons is not sufficient.
Finally, the modification in anxiety-related behavior observed in
our study seems to be independent of an increase in corticosterone
secretion that could modify the activity of other brain structures.
Thus, transgenic mice did not exhibit any alteration in basal
circulating plasma corticosterone levels and showed reduced stress-
induced corticosterone secretion. Although these results may seem
surprising, they are in agreement with what has been found using
mice overexpressing full-length GR which display unmodified
corticosterone secretion during the circadian cycle [43] and
decreased corticosterone secretion after stress [56]. This dumped
stress-induced corticosterone secretion is probably due to an
increase in GR-mediated negative feedback that inhibits stress-
induced corticosterone [57].
Downstream signaling pathway mediated by GR
activation in the hippocampus
Increased DGR expression in the DG was also associated with
an increase in the expression and enzymatic activity of the MAPK
signaling pathway which resulted in increased expression of the
zinc finger transcription factor Egr-1.
These results are important for several reasons. First, they show
at a molecular level that overexpression of the DGR in the DG is
functionally active in vivo extending previous results obtained in
vitro with the DGR [8]. Secondly, they shed some light on the
potential mechanisms through which DGR overexpression could
modify reactivity to threatening stimuli. Indeed, inhibition of the
MAPK pathway has been shown to decrease glutamate release
[58,59]. Glutamate that is increased by stress [58,60–65] through
glucocorticoids in the hippocampus [63,64,66,67,67–69] has
recently been shown to play an important role in stress responses
and anxiety disorders [70]. Therefore, it seems reasonable to
hypothesize that the increase in anxiety observed in DGR animals
could be mediated by a MAPK-dependent increase in the release
of glutamate.
Conclusions
In conclusion our data provide evidence that the anxiety-related
effects of glucocorticoid involve the activation of the GR in
glutamatergic neurons of the DG of the hippocampus. Our results
also restrict these behavioral modifications to transcriptional
effects of the GR that do not need the hormone binding and the
AF2 domains and point to an involvement of the MAPK signaling
pathway and the downstream MAPK-regulated protein Egr-1.
The identification of a neural target for anxiety-related effects of
GR activation may open the way to underpin the precise
molecular basis of certain stress-related disorders.
Materials and Methods
Animals
Tet-DGR/EGFP founder mice were amplified under C57BL/
6J (Charles River, Lyon, France) genetic background. Mice
expressing the transgene for the tetracycline transactivator (tTA)
under the control of the Enolase (Eno2) promoter, kindly provided
by Dr. E.J. Nestler (University of Texas Southwestern Medical
Center) [13], were backcrossed for seven generations to maintain
their homozygous state. Breeding homozygous Eno2-tTA and
heterozygous Tet-DGR/EGFP mice yields 50% bigenic mice and
50% Eno2-tTA mice used as control littermates. A 12 hr light/
dark cycle (lights on from 7am to 7pm) was used in the animal
house. Food (SAFE: Scientific Animal Food and Engineering
#A04, France) and water were available ad libitum. Animals were
maintained in a temperature (2261uC) and humidity (5565%)
controlled environment. All experiments were conducted in strict
compliance with the European Communities Council Directive of
24 November 1986 (86/609/EEC), and approved by the
Aquitaine-Poitou Charentes ethical committee.
Plasmid construction and in vivo gene targeting
Transgenic construct. The pBI-EGFP-TetO-DGR vector
used to generate transgenic animals transcribes two genes (egfp and
Dgr) from one bidirectional Tet-responsive promoter. It was
obtained by sequentially cloning the egfp and the Dgr genes under
the control of the Tet Response Elements (TRE) (Revest et al. [8]
for a detailed description). The pBI-DGR-TetO-EGFP construct
was then excised from the plasmid backbone by PshAI/HaeII
digestion. Microinjection into fertilized (C57BL/6JxCBA) F2
oocytes and other surgical procedures were performed within
the transgenic core facility at Bordeaux 2 University.
Genotyping. Genomic DNA was isolated from tail clips and
blood and genotype determined using different sets of primers to
discriminate between monogenic heterozygous Eno2-tTA and
bigenic Eno2-DGR/EGFP mice. PCR protocols using Taq
Polymerase (Biolabs, UK) to analyze tTA and DGR transgenes
respectively were 95uC 1 min, then 35 cycles of 95uC 45 sec, 56uC
45 sec, 72uC 2 min, then 72uC 10 min; and 95uC 1 min, then 30
cycles of 95uC 45 sec, 65uC 45 sec, 72uC 3 min 30 sec, then 72uC
10 min.
Primer tTA forward: 59-CGCTGTGGGGCATTTTACTT-
TAG-39;
primer tTA reverse: 59-CATGTCCAGATCGAAATCGTC-39.
Primer DGR forward: 59-tacccgggtcgagtaggcgtgtac-39;
primer DGR reverse: 59-GGCTTGATAAGATTGTATCTC-
CAG-39.
The transgene copy number was evaluated using real time
quantitative PCR (qPCR) by determining the threshold cycle (Ct)
of the transgene and a standard curve generated from a serial
dilution of known quantities of the pBI-DGR-TetO-EGFP cDNA
plasmid [25]. Briefly, genomic DNA isolated from the tail by
proteinase K digestion was used, followed by phenol-chloroform
extraction to remove real-time PCR inhibitors. qPCR amplifica-
tion used sets of specific primers to amplify both EGFP and actine
genes.
Primer EGFP forward: 59-GGGCACAAGCTGGAGTACAA-
CTA-39;
primer EGFP reverse: 59-CCTTGATGCCGTTCTTCGC-39.
Primer Actine forward: 59-TGACCGAGCGTGGCTACA-39;
primer Actine reverse: 59-CATAGCACAGCTTCTCTTT-
GATGTC-39.
All samples were run in triplicate using the Dynamo HS SYBR
Green qPCR kit (FINNZYME, Espoo, Finland) according to the
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cycler (MJ Research/Biorad, Hercules, CA, USA) using the
following amplification parameters 95uC 15 min, and 40 cycles at
95uC 20 sec and 61uC 35 sec. Fluorescence at each cycle was
normalized to the reference dye and the parameter Ct (threshold
cycle) was defined as the fractional cycle number above the
background noise at which the fluorescence passes a fixed
threshold. The copy number of genomic transgenes was calculated
based on the following formula:
(http://www.appliedbiosystems.com/support/tutorials/pdf/
quant_pcr.pdf) also including the mass of the haploid mouse
genome (C-value) which is around 3.28 pg (http://www.
genomesize.com).
Blood collection for corticosterone assay
For all the experiments described below blood was collected
through a small incision at the base of the tail vein made with a
razor blade which allowed the collection of 30 ml of blood. Blood
obtained via tail sampling was collected individually in capillaries
coated with heparine-litium (Sarstedt, France) and centrifuged at
13,000 rpm (4uC, 10 min). Supernatant containing the blood
plasma was stored at 220uC, and then processed for corticoste-
rone assay.
Circadian cycle experiment: Blood samples from Eno2-
DGR/EGFP and their control littermates were collected one hour
after light on and one hour after light off. During the dark period,
blood sampling took place under red light conditions.
Stress experiment: A first blood sample was taken 60
minutes (t260=basal condition) before the beginning of the stress
(t0). Mutant and control male mice were then subjected to 30
minutes stress in a brightly lit (500 lux) square open field
(50650 cm640 cm high). Twelve open fields were located in an
isolated room and 12 mice were tested in parallel. The
experimenter was not present in the room during the 30 minute
period and was unaware of the experimental group. Immediately
after the end of the 30 minutes stress procedure a blood sample
was collected by a small incision of the tail (t30). Animals were then
placed back into their home cages and blood samples were taken
75 (t75), 120 (t120) and 180 (t180) minutes after stress onset. Blood
samples from the same animal were collected from 5 distal to
proximal incisions of the tail vein corresponding to the 5 times
studied.
Corticosterone assay
Plasma corticosterone levels were measured by radioimmuno-
assay (RIA) as described elsewhere [19] using a highly specific
corticosterone antiserum (MP Biomedicals, France). The mini-
mum level of detection was 0.1 mg/100 ml, and the intra- and
interassay coefficients of variation were approximately 4.5 and
10%, respectively.
Immunohistochemistry
Mice were perfused transcardially with a phosphate-buffered
solution of 4% paraformaldehyde and 0.25% glutaraldehyde in
0.1 M phosphate buffer at pH 7.4. After perfusion, 40 mm brain
sections were cut on a vibratome and processed with a standard
immunohistochemical procedure using specific primary antibod-
ies. Free-floating sections were quenched with 0,5% NaBH4, 0,2%
Na2S2O5 in 0.1 M phosphate-buffered saline at pH 7.4 for 20
minutes to remove the unbound excess of aldehydes, then washed
3 times with PBS containing 0,2% Na2S2O5 and then were
processed according to a standard immunohistochemical proce-
dure. Briefly, sections were subjected to 72 h of incubation at 4uC
respectively: for NeuN-ImmunoReactivity (IR) using an anti-
NeuN mouse monoclonal antibody (1/1000, Chemicon, USA); for
NSE-IR using an anti-NSE (NSE: Neuron Specific Enolase) rabbit
polyclonal antibody (1/250, Chemicon, USA); for Glutamate-IR
using an anti-Glutamate mouse monoclonal antibody (1/1000,
Gemacbio, France), for Egr-1 using a polyclonal rabbit anti-Egr-1
(1/500 Santa Cruz, USA). Sections were then incubated with Cy
3
conjugated-secondary antibodies for 2 h at room temperature,
then washed and mounted on Superfrost Plus slides (Men-
zelGmbH&Co KG, Braunschweig, Germany) with mowiol or
ProLong Gold Antifade Reagent containing DAPI (Molecular
Probes-Invitrogen, UK). Confocal microscopic imaging was
performed using a Leica microscope (DMR TCS SP2 AOBS).
For EGFP immunostaining, a standard immunohistochemical
procedure was used [71]. Sections were incubated with a rabbit
polyclonal anti-EGFP antibody (#8367-1; 1/500, Clontech).
Immunoreactivities were visualized by the biotin-streptavidin
technique (ABC kit, Dako) using 3,39-diaminobenzidine as a
chromogen. Microscopic imaging was performed using a Leica
microscope DMRXA2 equipped with a Nomarski filter.
Immunoblotting analysis
Protein extracts containing protease and phosphatase inhibitors
from mice hippocampi were prepared using a procedure
previously described and validated [19]. Proteins suspended in
Laemmli buffer were separated by SDS-PAGE (10% gels),
transferred onto PVDF membranes (Millipore, US) and revealed
with specific antibodies. The following rabbit polyclonal antibodies
were used: anti-GR (#sc-1004-X; 1/10000, Santa Cruz), anti-
EGFP (#8367-1; 1/1000, Clontech), anti-Egr-1 (#sc-189; 1/500,
Santa Cruz), anti-MAP kinase (#06-182; 1/200000, Upstate),
anti-P-MAPK (#9101; 1/1000, Cell Signalling Technology).
Eurogentec provided the Neuronal Class III b-Tubulin (TUJ1)
monoclonal antibody (#MMS-435P, 1/20000). The X-Ray films
were quantified by densitometry using a GS-800 scanner (in
transmission mode) and the associated Quantity One software
(Bio-Rad, CA, USA) following the manufacturer’s instructions.
Behavioral experiments
Behavioral experiments were conducted on mutant and control
male mice, housed individually (dimension of the housing cage:
length 29 cm; width 11 cm; height 13 cm) for the 15 days
preceding the tests. All behavioral tests took place between 8am
and 1pm. To eliminate odor cues, all testing equipment was
thoroughly cleaned after each animal.
Elevated Plus Maze (EPM). The apparatus consists in
an elevated cross formed by two open arms (without walls,
length=45 cm, width=5 cm) and two closed arms (length=
45 cm, width=5 cm, height=15 cm) made of Plexiglas radiating
from a central platform to form a plus-sign. The apparatus was
situated 51 cm above the floor. Brightness is adjusted to 100 lux
for each area of the maze. Mice behavior was recorded by a video
camera positioned above the maze and the number of entries into
open and closed arms and the time spent on each arm were
recorded (Vide ´otrack, Viewpoint, Lyon France). The open arms
are considered by mice as a threatening area. Animals were placed
into the central area facing one open arm and allowed to explore
the maze for 5 minutes. Percentage of time in open arms (OA)
(time spent in open arms/(time spent in open + enclosed
arms)x100), and time spent in OA and the number of closed
and end-arm entries, were calculated [72–74]. To study the effects
of anxiolytics, mutant mice were injected intraperitoneally with
control solution or 7.5 mg/kg chlordiazepoxide (CDZ) [47].
Briefly, the benzodiazepine Chlordiazepoxide hydrochloride
(CDZ, Sigma-RBI, USA) was dissolved with Cremophor EL
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Cremophor EL alone in saline solution was used as control
solution. All injections were performed in a volume of 10 ml/g of
body weight. Fifteen minutes after the injection, both groups were
tested in the EPM.
Emergence test. This test was performed in a brightly lit
(500 lux) open field (50650 cm640 cm high) containing an
opaque cylinder (10-cm-deep and 6.5 cm in diameter) located
lengthwise along one wall, with the open end 10 cm from the
corner. During the test session which lasted 15 minutes the
behavior was videotaped and then scored by a trained observer
blind to genotype. At the beginning of the test session each mouse
was placed in the cylinder and the latency to leave the cylinder
(defined as placement of all four paws in the open field) and the
locomotor activity in the open field were evaluated. The latency to
emerge from the cylinder to go in the open space, which is a
threatening area for the mice, is considered as an index of anxiety
[32].
Forced swim test. In this test mice are forced to swim in a
small transparent cylinder (19 cm in diameter and 25 cm high)
filled with water (25uC, 20 cm deep) to avoid temperature-related
stress responses. After unsuccessful attempts to escape, animals
stop swimming and float. A mouse was judged immobile when it
stopped all active behaviors (i.e. struggling, swimming, and
jumping) and remained passively floating. Floating is considered
as a measure of despair (learned helplessness) because the animals
appear to stop trying to escape [29]. Behavior was recorded by a
video camera positioned above the cylinders and the duration that
each animal remained immobile as well as the latency to the first
immobilization was measured over a 6-minute test period.
Novel object test. This is a free exploration paradigm
providing the opportunity for the mice to explore a novel object
in a non-threatening and familiar environment. For this test mice
were first familiarized with the open field (50650 cm640 cm high)
apparatus. Five days later, they were allowed to freely explore the
open field in the absence of the object for 30 minutes (session 1,
S1). Then, a novel object (a cup measuring 18 cm in height and
7 cm in diameter) was placed into the center of the open field.
Mice were tested for an additional 30 minutes with the cup
(Session 2; S2). The computer defined grid lines that divided the
open field into five separate regions: one circular region in the
center with a diameter of 20 cm and a surrounding region that
was divided into quarters with gridlines that extended from the
middle of each wall to the edge of the center region. The ratio S2/
S1 measuring the distance and the time spent respectively in the
presence (Session 2; S2) and in the absence (Session 1; S1) of the
novel object were assessed by an automated video-tracking system.
Locomotor activity. Horizontal and vertical locomotor
activities were measured in sixteen rectangular boxes by beam
breaks via a fully computerized multi-box infrared sensitive
motion-detection system. One mouse was placed in each box;
sixteen mice were tested simultaneously. The apparatus consisted
of sixteen rectangular boxes (length: 20.5 cm; width: 10.5 cm;
high: 17.5 cm) isolated from one another by sound proof
compartments. Two pairs of sending–receiving photoelectric
cells were placed on each side of the activity boxes.
Water maze (WM). Mice were required to locate a fixed
hidden platform using distal extra-maze cues. On each training
day, mice were released into the water facing the wall of the pool.
Animals received three trials a day with a 5-minute inter-trial
interval and at each trial the start position was changed. This
procedure requires the hippocampus since the animal has to
learn the positional relations among multiple independent
environmental cues (‘‘spatial relational memory’’) in order to
find the hidden platform. Daily trials lasted 60 seconds each and
were stopped if the mouse reached the submerged platform where
they were maintained for 15 seconds. If the platform was not
found within 60 seconds mice were put on the platform and
maintained there for 15 seconds. The probe test was performed by
removing the platform and allowing each mouse to swim freely for
60 seconds inside the pool. The time that each mouse spent and
the distance it swam in the target quadrant (where the platform
was located during training) were recorded with a computerized
video system. The water maze consisted of a circular pool (150 cm
in diameter) filled with water mixed with a non-toxic white
cosmetic adjuvant to obscure the platform and maintained at a
temperature 2362uC. The escape platform (15 cm in diameter)
was submerged 1.0 cm below the surface. The maze was
operationally sectioned into four equal quadrants of NW, NE,
SW, and SE. Location of the platform remained in the centre of
northwest quadrant throughout the training period. Differential
visual spatial cues were placed on the walls surrounding the
cylindrical tank and corresponding to quadrant corners. The
swimming path of the animal was analyzed using a computerized
video tracking system which calculated the latency to reach the
platform, the length of the swim path and swim speed. WM
experiment consisted of 10 days of training and a probe trial on
day 11.
Statistics
The normality of the data distribution was verified using the
Shapiro-Wilk normality test and for homogeneity of variance we
used Levene and Brown & Forsythe’s tests. Data obtained for all
control and mutant mice did satisfy the assumptions of normality,
required for parametric analysis. Consequently, parametric
statistics were performed. Statistical significance was assessed by
ANOVA for repeated measures followed by post hoc comparisons
(Newman-Keuls test) or by Student’s t-test when appropriate. All
values were expressed as mean 6 s.e.m. Statistical significance was
expressed as *=P,0.05; **=P,0.01; ***=P,0.001.
Supporting Information
Figure S1 Cellular characterization of cells expressing EGFP
and DGR proteins in the cortex of Eno2-DGR/EGFP bigenic
mice. Confocal illustrations of neurons from the cortex co-
expressing EGFP protein and specific neuronal markers visualized
with Cy
3-conjugated antibodies. Distribution of EGFP and
endogenous neuronal markers (NeuN, NSE, Glutamate) and
merges of the two signals are shown.
Found at: doi:10.1371/journal.pone.0007704.s001 (7.20 MB TIF)
Figure S2 Quantification of the EGFP-TetO-DGR transgene
copy number by real time quantitative PCR (qPCR). The
quantification was performed by relating the PCR signal to a
standard curve. Eno2-DGR/EGFP bigenic mice contained 2
copies of the EGFP-TetO-DGR expression vector.
Found at: doi:10.1371/journal.pone.0007704.s002 (0.36 MB TIF)
Figure S3 Comparison of the brain expression pattern of two
independent Eno2-DGR/EGFP bigenic lines. The DG positive
line (L27) used in our experiments had a restricted expression
pattern in the DG and few positive cells in the cortex, whilst the
DG negative line (L23) expressed the DGR in the dorsal and
ventral striatum, in the cortex, in the CA1 of the hippocampus but
not in the DG.
Found at: doi:10.1371/journal.pone.0007704.s003 (9.53 MB TIF)
Figure S4 Behavioral comparisons between the DG positive line
(L27) and the DG negative line (L23). Any of the behavioral
GR in the DG Increase Anxiety
PLoS ONE | www.plosone.org 12 November 2009 | Volume 4 | Issue 11 | e7704phenotypes that were significantly modified in Line 27 showed
significant changes in Line 23. Elevated Plus Maze test; (A-A’)
Time in open arms (OA)/total time (%) (t20=20.623 p.0.538 for
A’), (B-B’) Time in open arms (sec) (t20=20.968 p.0.343 for B’),
(C-C’) Entries in open arms extremities (Nb) (t20=21.473
p.0.155 for C’), (D-D’) Closed arms entries (Nb) (t20=20.223
p.0.824 for D’). Emergence test; (E-E’) Latency to exit (sec)
(t20=20.210 p.0.835 for E’), (F-F’) Locomotor activity (m)
(t20=20.188 p.0.851 for F’). Forced swim test; (G-G’) First
immobilization latency (sec) (t22=20.078 p.0.937 for G’), (H-H’)
Duration of immobility (sec) (t22=20.450 p.0.655 for H’).
Statistical measures for panels A-H are given within the Results
section. Values shown are means +/2 sem. *=P,0.05;
**=P,0.01.
Found at: doi:10.1371/journal.pone.0007704.s004 (4.46 MB TIF)
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